ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 677169 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 677169; 2) Community: the network communities that were significantly associated with the response to NSC 677169; 3) Molecule: the relationships between components within communities and NSC 677169; 4) MDR: the compounds that were significantly associated with the NSC 677169.

NSC Compound Enrichment Correlation
NSC 3424 Acridine, 9-(4-[bis(2-chloroethyl)amino]-1-methylbutylamino)-6-chloro-2-methoxy-, dihydrochloride 0.000429167759775562 0.58782789
NSC 676600 Null 0.000429167759775562 -0.29658216
NSC 680420 Null 0.000429167759775562 0.28992805
NSC 692739 Null 0.000429167759775562 0.30063714
NSC 95099 Bigitalin 0.000429167759775562 0.4271334
NSC 137679 9H-Purine-6(1H)-one, 2-amino-9-.beta.-D-ribofuranosyl-6-seleno- 0.000573863872925591 0.29818199
NSC 275656 m-Dioxane-5-methanol, 2,2-dimethyl-5-(4,6-diaziridinyl-2-S-triazinylamino)- 0.000573863872925591 0.5011854
NSC 606985 Camptothecin Derivative 0.000573863872925591 0.34530021
NSC 659949 14-Bromo-7-O-(2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexo- pyranosyl)-4-demethoxydaunomycinone 0.000573863872925591 0.40463823
NSC 682011 Benzimidazo[1,2-b]isoquinoline-6-carbonitrile, 7,8,9,10-tetrahydro-11-[(4-fluorophenyl)amino]- 0.000573863872925603 0.13911628
Total:95  Current:4    [First] [Prev] [Next] [Last]